MFSD6L Activators
1,1-Dimethylbiguanide, Hydrochloride and Phenformin, by triggering AMPK, drive cellular energy balance towards a state that supports the functional readiness of MFSD6L. AICAR, mimicking AMP's structure, taps into this energy-sensing pathway, ensuring that the energy status within the cell is conducive to the mobilization of MFSD6L. Berberine, on the other hand, while also an AMPK activator, introduces additional layers of metabolic modulation, which can influence the protein's activity.
SIRT1 activators like Resveratrol and SRT1720 delve deeper into the cell's metabolic core, enhancing mitochondrial function, which is intrinsically tied to the overall metabolic activity. This improvement in energy efficiency can echo through to MFSD6L, facilitating its operational capacity. PPAR agonists such as Pioglitazone, Rosiglitazone, GW501516, and Ciglitazone recalibrate lipid metabolism, which is a crucial factor for the membrane-bound MFSD6L, potentially altering its dynamics and function. Forskolin stands out by amplifying cAMP levels, thereby influencing various cAMP-dependent processes that can cascade down to affect the workings of MFSD6L. Quercetin, with its versatile impact on cellular mechanisms, including those modulated by AMPK and SIRT1, suggests that a wide array of signaling pathways can converge to modulate the activity of MFSD6L.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
AMPK pathway activator that can enhance glucose transport and may affect MFSD6L by modulating cellular energy status. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AMP analog that activates AMPK and may influence MFSD6L activity by altering cellular energy balance. | ||||||
Phenformin Hydrochloride | 834-28-6 | sc-219590 | 10 g | $119.00 | 4 | |
AMPK activator that can indirectly influence MFSD6L activity through modulation of cellular metabolism. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
Plant alkaloid that can activate AMPK, potentially affecting MFSD6L by altering metabolic processes. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
SIRT1 activator that can support cellular energy balance and may indirectly affect MFSD6L function. | ||||||
SRT1720 | 1001645-58-4 | sc-364624 sc-364624A | 5 mg 10 mg | $197.00 $364.00 | 13 | |
SIRT1 activator that can enhance mitochondrial function and may indirectly influence MFSD6L activity by improving cellular energy status. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
PPAR-γ agonist that can alter lipid metabolism and may have an indirect effect on MFSD6L activity by modifying the cellular lipid environment. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
PPAR-γ agonist with potential to alter MFSD6L activity by affecting lipid handling in cells. | ||||||
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $82.00 $179.00 | 28 | |
PPAR-δ agonist that can change energy usage patterns in cells and may indirectly affect MFSD6L function. | ||||||
Ciglitazone | 74772-77-3 | sc-200902 sc-200902A | 5 mg 25 mg | $104.00 $428.00 | 10 | |
PPAR-γ agonist that can affect glucose and lipid metabolism, potentially altering MFSD6L activity through metabolic changes. | ||||||